483
Nephron Sc IncFDA 483 - Nephron Sc Inc - April 20, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Nephron Sc Inc, a drug manufacturer in West Columbia, SC, was cited for significant deficiencies during an FDA inspection. The observations include failures to thoroughly investigate unexplained discrepancies, inadequate laboratory controls for sterility testing, and deficiencies in environmental monitoring within aseptic processing areas. These issues indicate a lack of robust quality control and assurance processes.
Open in Dashboard
ID · 3dd6396e-f65d-40e5-9652-35c68210bbcd